Trihydroxy-Delta-9-Tetrahydrocannabinol (triOH-THC) is a rare and lesser-known metabolite of Delta-9-Tetrahydrocannabinol (THC), characterized by the presence of three hydroxyl (-OH) groups in its molecular structure. These hydroxyl groups increase its polarity, potentially altering its interaction with cannabinoid receptors and its overall pharmacokinetics. While non-psychoactive in its natural form, triOH-THC is gaining attention for its possible role in therapeutic applications, including anti-inflammatory and neuroprotective effects.
